Corticotropin-Releasing Factor Stimulation Test

Alan N. Elias, Grant Gwiniip, George P. Chrousos, Lynnette Nieman, Bruce Nisula, Gordon B. Cutler, Donald (Lynn) Loriaux, Heinrich M. Schulte, Philip W. Gold, Edward H. Oldeield

Research output: Contribution to journalLetter

5 Citations (Scopus)

Abstract

To the Editor: 'The paper by Chrousos et al. on corlicolropinreleasing factor as an aid in the diagnosis of Cushing's disease (March 8 issue)1 fails to take into consideration the fact that the pituitary tumors responsible for Cushing's disease are not homogeneous. As shown by Lamberts et al., a major proportion of these tumors are rich in neural tissue and behave differently in response to provocative and inhibitory stimuli than do antcrior-lobc tumors.2 Such ACTH-sccreting ncurointermcdiate-lobc tumors are relatively refractory to glucocorticoid suppression but are suppressed by the dopamine agonist bromocriptine. We and others have found that possible neurointermediate-lobc tumors.

Original languageEnglish (US)
Pages (from-to)471-473
Number of pages3
JournalNew England Journal of Medicine
Volume311
Issue number7
DOIs
StatePublished - Aug 16 1984
Externally publishedYes

Fingerprint

Corticotropin-Releasing Hormone
Pituitary ACTH Hypersecretion
Neoplasms
Bromocriptine
Dopamine Agonists
Pituitary Neoplasms
Adrenocorticotropic Hormone
Glucocorticoids

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Elias, A. N., Gwiniip, G., Chrousos, G. P., Nieman, L., Nisula, B., Cutler, G. B., ... Oldeield, E. H. (1984). Corticotropin-Releasing Factor Stimulation Test. New England Journal of Medicine, 311(7), 471-473. https://doi.org/10.1056/NEJM198408163110719

Corticotropin-Releasing Factor Stimulation Test. / Elias, Alan N.; Gwiniip, Grant; Chrousos, George P.; Nieman, Lynnette; Nisula, Bruce; Cutler, Gordon B.; Loriaux, Donald (Lynn); Schulte, Heinrich M.; Gold, Philip W.; Oldeield, Edward H.

In: New England Journal of Medicine, Vol. 311, No. 7, 16.08.1984, p. 471-473.

Research output: Contribution to journalLetter

Elias, AN, Gwiniip, G, Chrousos, GP, Nieman, L, Nisula, B, Cutler, GB, Loriaux, DL, Schulte, HM, Gold, PW & Oldeield, EH 1984, 'Corticotropin-Releasing Factor Stimulation Test', New England Journal of Medicine, vol. 311, no. 7, pp. 471-473. https://doi.org/10.1056/NEJM198408163110719
Elias AN, Gwiniip G, Chrousos GP, Nieman L, Nisula B, Cutler GB et al. Corticotropin-Releasing Factor Stimulation Test. New England Journal of Medicine. 1984 Aug 16;311(7):471-473. https://doi.org/10.1056/NEJM198408163110719
Elias, Alan N. ; Gwiniip, Grant ; Chrousos, George P. ; Nieman, Lynnette ; Nisula, Bruce ; Cutler, Gordon B. ; Loriaux, Donald (Lynn) ; Schulte, Heinrich M. ; Gold, Philip W. ; Oldeield, Edward H. / Corticotropin-Releasing Factor Stimulation Test. In: New England Journal of Medicine. 1984 ; Vol. 311, No. 7. pp. 471-473.
@article{9d7236bc595c43ac8fe7174c4c39b3a2,
title = "Corticotropin-Releasing Factor Stimulation Test",
abstract = "To the Editor: 'The paper by Chrousos et al. on corlicolropinreleasing factor as an aid in the diagnosis of Cushing's disease (March 8 issue)1 fails to take into consideration the fact that the pituitary tumors responsible for Cushing's disease are not homogeneous. As shown by Lamberts et al., a major proportion of these tumors are rich in neural tissue and behave differently in response to provocative and inhibitory stimuli than do antcrior-lobc tumors.2 Such ACTH-sccreting ncurointermcdiate-lobc tumors are relatively refractory to glucocorticoid suppression but are suppressed by the dopamine agonist bromocriptine. We and others have found that possible neurointermediate-lobc tumors.",
author = "Elias, {Alan N.} and Grant Gwiniip and Chrousos, {George P.} and Lynnette Nieman and Bruce Nisula and Cutler, {Gordon B.} and Loriaux, {Donald (Lynn)} and Schulte, {Heinrich M.} and Gold, {Philip W.} and Oldeield, {Edward H.}",
year = "1984",
month = "8",
day = "16",
doi = "10.1056/NEJM198408163110719",
language = "English (US)",
volume = "311",
pages = "471--473",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "7",

}

TY - JOUR

T1 - Corticotropin-Releasing Factor Stimulation Test

AU - Elias, Alan N.

AU - Gwiniip, Grant

AU - Chrousos, George P.

AU - Nieman, Lynnette

AU - Nisula, Bruce

AU - Cutler, Gordon B.

AU - Loriaux, Donald (Lynn)

AU - Schulte, Heinrich M.

AU - Gold, Philip W.

AU - Oldeield, Edward H.

PY - 1984/8/16

Y1 - 1984/8/16

N2 - To the Editor: 'The paper by Chrousos et al. on corlicolropinreleasing factor as an aid in the diagnosis of Cushing's disease (March 8 issue)1 fails to take into consideration the fact that the pituitary tumors responsible for Cushing's disease are not homogeneous. As shown by Lamberts et al., a major proportion of these tumors are rich in neural tissue and behave differently in response to provocative and inhibitory stimuli than do antcrior-lobc tumors.2 Such ACTH-sccreting ncurointermcdiate-lobc tumors are relatively refractory to glucocorticoid suppression but are suppressed by the dopamine agonist bromocriptine. We and others have found that possible neurointermediate-lobc tumors.

AB - To the Editor: 'The paper by Chrousos et al. on corlicolropinreleasing factor as an aid in the diagnosis of Cushing's disease (March 8 issue)1 fails to take into consideration the fact that the pituitary tumors responsible for Cushing's disease are not homogeneous. As shown by Lamberts et al., a major proportion of these tumors are rich in neural tissue and behave differently in response to provocative and inhibitory stimuli than do antcrior-lobc tumors.2 Such ACTH-sccreting ncurointermcdiate-lobc tumors are relatively refractory to glucocorticoid suppression but are suppressed by the dopamine agonist bromocriptine. We and others have found that possible neurointermediate-lobc tumors.

UR - http://www.scopus.com/inward/record.url?scp=0021172940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021172940&partnerID=8YFLogxK

U2 - 10.1056/NEJM198408163110719

DO - 10.1056/NEJM198408163110719

M3 - Letter

VL - 311

SP - 471

EP - 473

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 7

ER -